Putting A Q-Tip Inside Your Ear Is A BIG Mistake! This Is How You Should Clean Your Ears

The earwax inside the ears has a purpose, which is protecting the ear canal. It actually helps the ear clean itself and stay lubricated, protecting it thus from bacteria, water, insects, fungi, etc. the earwax is also called cerumen, which is the medical term.

The cerumen represents a protective barrier which saves the delicate and the sensitive skin inside the external auditory canal from harm.

From time to time, the earwax accumulates in the ear in greater quantities. The majority of people do not know how to use the Q-tips and put them inside their ears in order to clean them. Even though it sounds weird, the ear wax is actually good for you. Placing a Q-tip anywhere with the exception of the outermost parts of the ear can cause a lot of harm to your health.

It is recommended that when there is some earwax in your ears, you just leave it alone. The ear has a magically, wonderfully working system which works in the following way: the skin grows outward gradually and it almost forms a little conveyor belt that carries the earwax out.

Read more: Putting A Q-Tip Inside Your Ear Is A BIG Mistake! This Is How You Should Clean Your Ears

Source: non-stophealthy

The superbug that doctors have been dreading just reached the U.S.

For the first time, researchers have found a person in the United States carrying bacteria resistant to antibiotics of last resort, an alarming development that the top U.S. public health official says could mean “the end of the road” for antibiotics.

The antibiotic-resistant strain was found last month in the urine of a 49-year-old Pennsylvania woman. Defense Department researchers determined that she carried a strain of E. coli resistant to the antibiotic colistin, according to a study published Thursday in Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology. The authors wrote that the discovery “heralds the emergence of a truly pan-drug resistant bacteria.”

Read more: The PhD journey: A guide to applying, starting and succeeding

Source: washingtonpost

The PhD journey: A guide to applying, starting and succeeding

To postgraduates, a PhD may seem like an ideal opportunity to improve research skills prior to future work. However, the application process is a competitive and often challenging experience. This article seeks to de-mystify some of the common questions surrounding PhD applications and provide some hints and tips for potential applicants.

1. Is a PhD for you?

An increasing number of postgraduates are applying for PhD study to develop their academic and professional skills. However, before you begin to consider searching for positions, you must be fully aware of what studying for a PhD actually entails. A PhD is the highest degree a person can achieve. It will involve around three years’ full-time (up to six years’ part-time) work, culminating in a thesis of somewhere around 80,000 words. It is research-intensive, with you developing and leading projects and writing papers in your chosen field of study. Although you will have the support of two or more specialist supervisors, a PhD is by-and-large independent work.

Read more: The PhD journey: A guide to applying, starting and succeeding

Source: academia

Download: link

Not unexpectedly, a new drug-resistant ‘superbug’ pops up in the United States

For years, public health experts have warned us that deadly bacteria are developing resistance to all our available antibiotics. This week, researchers reported the first known U.S. case of an Escherichia coli infection resistant to colistin, a harsh drug seen as a last resort to knock out stubborn infections. The finding, described in the American Society for Microbiology journal Antimicrobial Agents and Chemotherapy, is no big surprise to researchers tracking the rise of resistant bacteria. The resistance gene, known as mcr-1, was discovered in E. coli in China last year, and has since cropped up in Europe.

As the United States crosses the same ominous milestone, research to understand resistance and develop new drugs is surging ahead. As Science reported earlier this month, evolutionary biologists have recently revisited old dogma about how best to prescribe antibiotics—revealing that trusted strategies such as using a high dose may not actually help prevent resistance.

Read more: Not unexpectedly, a new drug-resistant ‘superbug’ pops up in the United States

E. coli bacteria growing in a dish.

Source: sciencemag

Down syndrome points to key gene responsible for type 2 diabetes

One of the key genes responsible for the onset of type 2 diabetes has been identified, opening up possibilities to develop a drug to combat the condition.

Key points

• Onset of type 2 diabetes caused by failure of beta cells in the pancreas
• Failure of beta cells also often seen in people with Down syndrome, who have an extra copy of chromosome 21
• Comparison of beta cell genes on chromosome 21 and in people with type 2 diabetes narrows down one common gene called RCAN1

The discovery, published today in PLOS Genetics, was made by comparing genes involved with defects in insulin secretion of people with type 2 diabetes and those with Down syndrome.

Diabetes is the fastest-growing chronic condition in Australia with the preventable type 2 form accounting for 85 per cent of all cases.

Read more: Down syndrome points to key gene responsible for type 2 diabetes

Source: cdascher/Getty Images

DNA Purification

DNA purification, DNA extraction and DNA isolation are terms that are often used for the same processes. While DNA isolation aims to get as much of the DNA out of your sample as possible, DNA purification is done to reduce - or even eliminate - the contamination of the isolated DNA. Extraction is just one specific way to achieve isolation and purification. DNA extraction uses a solvent that serves as extractant and can be divided in above stages.

All three terms are often used for the same process which normally combines the DNA isolation and DNA purifcation.

Here at ZAGENO we realized how difficult it is to find the right DNA Purification Kit, DNA Extraction Kit, DNA Isolation Kit or DNA testing Kit. First of all one needs to define what type of DNA is to be extracted. Depending on the specific target ,a huge number of DNA test kits from many different suppliers exist:

• Plasmid DNA
• Genomic DNA
• Viral DNA
• cDNA

Read more: DNA Purification

Source: zageno

Lowering LDL Cholesterol: When Numbers are Not Enough

Clinicians worldwide continue to be challenged by cholesterol management for their patients; specifically, whether to attempt low-density lipoprotein (LDL-C) reduction to previously described targets, or to specific percent reductions (e.g., ≥ 50% or < 50%) based on an individual's risk assessment as advocated by the US Guidelines. Indeed, Canadian and European Guidelines suggest using both strategies. Data addressing whether the high-intensity statin strategy (to achieve ≥ 50% LDL-C reduction) correlates with improved cardiovascular outcomes is limited.

In addition, it is known that LDL-C reduction to the same strength of statin can vary widely in the population4 resulting in a significant number of patients who may continue to be at increased, potentially modifiable risk, for future events. Recently, the Treating to New Targets (TNT) investigators reported in their known coronary artery disease patient population that visit-to-visit variability in LDL-C levels correlated with increased cardiovascular risk, suggesting yet another possible contributor to residual risk, reportedly independent of LDL-C levels.

Read more: Lowering LDL Cholesterol: When Numbers are Not Enough

Source: acc

Plasma Levels Investigated as Alzheimer's Disease Biomarkers

The relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain volumetrics and cognitive performance has been investigated.

Since amyloid beta (Aβ) peptides are the main component of the amyloid plaques found in Alzheimer patients' brains, changes in levels of Aβ in blood plasma may provide a biomarker for detecting increased risk or early diagnosis of disease.

Scientists at the University of New South Wales (Sydney, Australia) examined 126 age-matched cognitively normal controls, 89 individuals with amnestic mild cognitive impairment (aMCI,) from the Center for Healthy Brain Aging (CHeBA) Sydney Memory & Aging Study (Sydney MAS), as well as 39 individuals with Alzheimer's disease (AD) recruited from a specialty clinic.

Read more: Plasma Levels Investigated as Alzheimer's Disease Biomarkers

A diagram of the formation of amyloid plaques in the brain of an Alzheimer brain compared
with a normal brain

Source: Junji Takano

Antibiotic resistance solution proposed

A group of US scientists are confident the key to tackling antibiotic resistant bacteria is already in front of our faces – non-antibiotic therapeutic drugs.

At least 50,000 people die every year in Europe and the US due to antibiotic resistance. In other areas of the world this figure is estimated to be in the hundreds of thousands.

Professor Ashok Chopra, from the University of Texas, said: “There are no new antibiotics which are being developed and nobody really has given much emphasis to this because everyone feels we have enough antibiotics in the market.

“But now the problem is bugs are becoming resistant to multiple antibiotics. That’s why we started thinking about looking at other molecules that could have some effect in killing antibiotic resistant bacteria.”

Read more: Antibiotic resistance solution proposed

Source: labnews

Precision Medicine in Oncology

The White House Proposes Increased Funding For a National Precision Medicine Initiative

In his 2015 State of the Union address, President Obama stated his intention to fund a national Precision Medicine Initiative (PMI), defined by the NIH as an emerging approach for disease prevention and treatment that takes into account individual variations in genes, environment, and lifestyle.

The White House said that it will ask Congress for $215 million to fund the assembly of databases. Through the data, from over one million patients, scientists and researchers will be able to individualize care and generate the requisite scientific evidence to move the concept of precision medicine into clinical practice.

The initiative, in the near-term, focuses on cancer, with other disease areas included over the longer term. Of the $215 million, the White House proposed $70 million in increased funding for the NCI to advance the field of precision oncology.

Basically the initiative funds efforts to integrate and apply the explosion of molecular data on humans, particularly data associated with individual patients, and taps into opportunities to use it to improve health outcomes. The “time is right” for the initiative, NIH says, because of the sequencing of the human genome, improved technologies for biomedical analysis, and new tools for using large datasets.

Read more: Precision Medicine in Oncology

MATCH clinical trials analyze tumors for abnormalities using a targeted sequencing

assay that includes 143 genes selected using the Oncomine Knowledgebase.

Source: Deposit Photos/alexraths